A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECT

American Journal of Transplantation

Volumn 12, Issue 7, 2012, Pages 1855-1865

  Fischer, L ^a   Klempnauer, J ^b   Beckebaum, S ^c   Metselaar, H J ^d   Neuhaus, P ^e   Schemmer, P ^f   Settmacher, U ^g   Heyne, N ^h   Clavien, P A ⁱ   Muehlbacher, F ^j   Morard, I ^k   Wolters, H ^l   Vogel, W ^m   Becker, T ⁿ   Sterneck, M ^a   Lehner, F ^b   Klein, C ^c   Kazemier, G ^d   Pascher, A ^e   Schmidt, J ^f   Rauchfuss, F ^g   Schnitzbauer, A ^o   Nadalin, S ^h   Hack, M ^p   Ladenburger, S ^p   Schlitt, Hans ^o   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g JENA UNIVERSITY HOSPITAL   (Germany)

^h UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁿ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^o UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^p NOVARTIS PHARMA GMBH   (Germany)

more..

Author keywords

Calcineurin inhibitor agents; Conversion; Everolimus; Liver transplantation; mTor inhibitor; Renal function

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; EVEROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HERPES SIMPLEX; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; LEUKOPENIA; LIVER BIOPSY; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RHINOPHARYNGITIS; SINUSITIS; URINARY TRACT INFECTION; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ADULT; CALCINEURIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 84863226512     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04049.x     Document Type: Article

References (20)

1. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940. (Pubitemid 37064766)
2. Cohen AJ, Stegall MD, Rosen CB, et al. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002; 8: 916-921. (Pubitemid 35154021)
3. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001; 72: 1934-1939. (Pubitemid 34027867)
4. Moreno JM, Cuervas-Mons V, Rubio E, et al. Chronic renal dysfunction after liver transplantation in adult patients: Prevalence, risk factors, and impact on mortality. Transplant Proc 2003; 35: 1907-1908. (Pubitemid 37093759)
5. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741-747. (Pubitemid 36874464)
6. Velidedeoglu E, Crawford MD, Desai NM, et al. Predictors of late kidney dysfunction post-liver transplantation. Transplant Proc 2002; 34: 3315-3316. (Pubitemid 35463331)
7. Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: Focus on improving renal function and nephrotoxicity. Clin Transplant 2008; 22: 1-15. (Pubitemid 351149996)
8. Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009; 22: 49-60.
9. Fung J, Marcos A. Rapamycin: Friend, foe, or misunderstood? Liver Transpl 2003; 9: 469-472. (Pubitemid 36621714)
10. Campsen J, Zimmerman MA, Mandell S, et al. A decade of experience using mTor inhibitors in liver transplantation. J Transplant 2011; Article ID 913094; 7 pages, 2011. doi:10.1155/2011/913094
11. Abdelmalek MF, Humar A, Stickel F et al. Sirolimus conversion regimen vs. continued calcineurin inhibitors in liver allograft recipients: a randomized trial. Am J Transplant 2012; 12: 694-705.
12. De Simone P, Metselaar HJ, Fischer L, et al. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial. Liver Transpl 2009; 15: 1262-1269.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
15. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transpl 2004; 10: 301-309. (Pubitemid 38240131)
16. Levy G, Schmidli H, Punch J, et al. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transpl 2006; 12: 1640-1648. (Pubitemid 44742543)
17. Masetti M, Montalti R, Rompianesi G, et al. Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function. Am J Transplant 2010; 10: 2252-2262.
18. Saliba F, De Simone P, Nevens F, et al. Efficacy and safety of everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients: 12 month results of a randomized, controlled study [abstract]. Hepatology 2011; 54: 1430A-1431A.
19. De Simone P, Carrai P, Precisi A, et al. Conversion to everolimus monotherapy in maintenance liver transplantation: Feasibility, safety, and impact on renal function. Transpl Int 2009; 22: 279-286.
20. De Simone P, Precisi A, Petruccelli S, et al. The impact of everolimus on renal function in maintenance liver transplantation. Transplant Proc 2009; 41: 1300-1302.